TORONTO, Oct. 03, 2024 (GLOBE NEWSWIRE) -- Arch Biopartners Inc., (“Arch” or the “Company”) (TSX Venture: ARCH and OTCQB: ACHFF)…
New 31,000 square-foot facility will enhance Legend’s leading cell therapy portfolio and expand Legend’s R&D capabilities as a global cell…
PALO ALTO, Calif., Oct. 03, 2024 (GLOBE NEWSWIRE) -- BridgeBio Pharma, Inc. (Nasdaq: BBIO) (“BridgeBio” or the “Company”), a commercial-stage…
FDA Orphan Products Grants are based on scientific and technical merit as determined by rare disease and regulatory experts Ongoing…
DATAcc is creating an open-source industry guide to address market challenges by bringing clarity on how and why to include…
GOTHENBURG, SE / ACCESSWIRE / October 3, 2024 / IRLAB Therapeutics (STO:IRLAB-A)(FRA:6IRA) Gothenburg, Sweden, October 3 2024 - IRLAB Therapeutics…
The First Digital Network for Research Flips the Script on Patient Recruitment PHILADELPHIA, Oct. 2, 2024 /PRNewswire/ -- Power, a…
AWS, Deloitte, Microsoft and NVIDIA bring the latest in AI technology, coordination, and compute to the alliance and back with…
DELRAY BEACH, Fla., Oct. 2, 2024 /PRNewswire/ -- The global life science analytics market is projected to grow from USD 35.69…
$34.9M ARPA-H project aims to disrupt therapies' market and radically improve treatment options HOUSTON, Oct. 2, 2024 /PRNewswire/ -- Rice…